Narcobarbital
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 125-55-3 |
| ATC code | N01AG01 |
| PubChem | CID 18735 |
| ChemSpider | 17691 |
| KEGG | C17722 |
| ChEMBL | CHEMBL92963 |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Mol. mass | 303.152 g/mol |
|
|
|
|
| |
|
Narcobarbital (Pronarcon) is a barbiturate derivative developed by Riedel de Hean in the 1930s.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.
References [edit]
- ^ US Patent 2080071
|
|||||||||||||||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |